Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO RAPID VITILIGO
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 22 Dec 2017
At a glance
- Drugs Apremilast (Primary)
- Indications Vitiligo
- Focus Therapeutic Use
- Acronyms Rapid Vitiligo
- 18 Dec 2017 Planned End Date changed from 1 Feb 2019 to 1 Mar 2019.
- 18 Dec 2017 Planned primary completion date changed from 1 Feb 2018 to 1 Apr 2018.
- 18 Dec 2017 Status changed from recruiting to active, no longer recruiting.